KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nov (NOV) EBT (2016 - 2025)

Nov's EBT history spans 17 years, with the latest figure at -$326.0 million for Q4 2025.

  • For Q4 2025, EBT fell 263.82% year-over-year to -$326.0 million; the TTM value through Dec 2025 reached $6.0 million, down 99.28%, while the annual FY2025 figure was $375.0 million, 54.87% down from the prior year.
  • EBT for Q4 2025 was -$326.0 million at Nov, down from $96.0 million in the prior quarter.
  • Across five years, EBT topped out at $293.0 million in Q2 2024 and bottomed at -$326.0 million in Q4 2025.
  • The 5-year median for EBT is $118.0 million (2025), against an average of $72.7 million.
  • The largest annual shift saw EBT surged 540.62% in 2022 before it plummeted 263.82% in 2025.
  • A 5-year view of EBT shows it stood at -$32.0 million in 2021, then soared by 540.62% to $141.0 million in 2022, then decreased by 4.26% to $135.0 million in 2023, then surged by 47.41% to $199.0 million in 2024, then tumbled by 263.82% to -$326.0 million in 2025.
  • Per Business Quant, the three most recent readings for NOV's EBT are -$326.0 million (Q4 2025), $96.0 million (Q3 2025), and $115.0 million (Q2 2025).